-+ 0.00%
-+ 0.00%
-+ 0.00%

Armata Pharmaceuticals appoints Pfizer executive Daniel Gilmer to board

PUBT·04/27/2026 11:01:41
Listen to the news
Armata Pharmaceuticals appoints Pfizer executive Daniel Gilmer to board
  • Armata Pharmaceuticals appointed Daniel B. Gilmer to board of directors, effective April 24, 2026.
  • Gilmer has served as senior director, Commercial Quality U.S. Team Lead at Pfizer since February 2025.
  • Earlier at Pfizer, he led cross-functional teams in Antiviral and Diagnostics business, including U.S. launch of PAXLOVID.
  • Gilmer is co-inventor on Exebacase (CF-301), a Streptococcus bacteriophage lysin that advanced to Phase 3 clinical trials.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Armata Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA43331) on April 27, 2026, and is solely responsible for the information contained therein.